India to Australia: Amphotericin Export Trade Route
India has recorded 32 verified shipments of Amphotericin exported to Australia, representing a combined trade value of $6.0M USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $186.7K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 100% of total export value with 13 shipments worth $6.0M USD. On the buying side, SUN PHARMA ANZ PTY LIMITED is the largest importer in Australia with $3.0M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYPHARS PHARMACEUTICS PVT LTD, ZYPHARS PHARMACEUTICS PRIVATE LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Amphotericin corridor is one of India's established pharmaceutical export routes, with 32 shipments documented worth a combined $6.0M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's amphotericin manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $186.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with amphotericin's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 20.0%, placing it at rank #20 among India's top amphotericin export destinations globally.
On the import side, key buyers of Indian amphotericin in Australia include SUN PHARMA ANZ PTY LIMITED, SUN PHARMA ANZ PTY LTD, SUN PHARMA ANZ PTY LTD. and 7 others. SUN PHARMA ANZ PTY LIMITED is the single largest importer with 7 shipments valued at $3.0M USD.
